Overview

Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate efficacy and safety of HP-3070 compared with placebo transdermal patch in subjects diagnosed with schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Noven Pharmaceuticals, Inc.
Treatments:
Asenapine
Maleic acid